• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

亨廷顿病外周血白细胞和小鼠纹状体中改变的 aconitase 2 活性。

Altered Aconitase 2 Activity in Huntington's Disease Peripheral Blood Cells and Mouse Model Striatum.

机构信息

Department of Neurology, Chang Gung Memorial Hospital, Linkou; Chang-Gung University College of Medicine, Taoyuan 33305, Taiwan.

出版信息

Int J Mol Sci. 2017 Nov 21;18(11):2480. doi: 10.3390/ijms18112480.

DOI:10.3390/ijms18112480
PMID:29160844
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5713446/
Abstract

Huntington's disease (HD) is caused by an unstable cytosine adenine guanine (CAG) trinucleotide repeat expansion encoding a polyglutamine tract in the huntingtin protein. Previously, we identified several up- and down-regulated protein molecules in the striatum of the Hdh knock-in mice at 16 months of age, a mouse model which is modeling the early human HD stage. Among those molecules, aconitase 2 (Aco2) located in the mitochondrial matrix is involved in the energy generation and susceptible to increased oxidative stress that would lead to inactivation of Aco2 activity. In this study, we demonstrate decreased Aco2 protein level and activity in the brain of both Hdh and R6/2 mice. Aco2 activity was decreased in striatum of Hdh mice at 16 months of age as well as R6/2 mice at 7 to 13 weeks of age. Aco2 activity in the striatum of R6/2 mice could be restored by the anti-oxidant, -acetyl-l-cysteine, supporting that decreased Aco2 activity in HD is probably caused by increased oxidative damage. Decreased Aco2 activity was further found in the peripheral blood mononuclear cells (PBMC) of both HD patients and pre-symptomatic HD mutation (PreHD) carriers, while the decreased Aco2 protein level of PBMC was only present in HD patients. Aco2 activity correlated significantly with motor score, independence scale, and functional capacity of the Unified Huntington's Disease Rating Scale as well as disease duration. Our study provides a potential biomarker to assess the disease status of HD patients and PreHD carriers.

摘要

亨廷顿病(HD)是由不稳定的胞嘧啶腺嘌呤鸟嘌呤(CAG)三核苷酸重复扩展引起的,该扩展在亨廷顿蛋白中编码一个多聚谷氨酰胺片段。以前,我们在 16 个月大的 Hdh 敲入小鼠纹状体中鉴定出几种上调和下调的蛋白质分子,这种小鼠模型模拟了人类 HD 的早期阶段。在这些分子中,位于线粒体基质中的 aconitase 2(Aco2)参与能量生成,并且容易受到增加的氧化应激的影响,这会导致 Aco2 活性失活。在这项研究中,我们证明了 Hdh 和 R6/2 小鼠的大脑中 Aco2 蛋白水平和活性降低。在 16 个月大的 Hdh 小鼠和 7 至 13 周大的 R6/2 小鼠的纹状体中,Aco2 活性降低。R6/2 小鼠纹状体中的 Aco2 活性可以通过抗氧化剂 - 乙酰 - l - 半胱氨酸恢复,支持 HD 中 Aco2 活性降低可能是由于氧化损伤增加所致。在 HD 患者和预症状 HD 突变(PreHD)携带者的外周血单核细胞(PBMC)中进一步发现 Aco2 活性降低,而 PBMC 中的 Aco2 蛋白水平降低仅存在于 HD 患者中。Aco2 活性与运动评分、独立性量表以及统一亨廷顿病评定量表的功能能力以及疾病持续时间显著相关。我们的研究为评估 HD 患者和 PreHD 携带者的疾病状况提供了一个潜在的生物标志物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ff0/5713446/efbc6eca12b2/ijms-18-02480-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ff0/5713446/99bf8f0fd81f/ijms-18-02480-g001a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ff0/5713446/d0868c8bb328/ijms-18-02480-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ff0/5713446/63bda583e370/ijms-18-02480-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ff0/5713446/8e2666b4624d/ijms-18-02480-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ff0/5713446/92314d043249/ijms-18-02480-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ff0/5713446/efbc6eca12b2/ijms-18-02480-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ff0/5713446/99bf8f0fd81f/ijms-18-02480-g001a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ff0/5713446/d0868c8bb328/ijms-18-02480-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ff0/5713446/63bda583e370/ijms-18-02480-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ff0/5713446/8e2666b4624d/ijms-18-02480-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ff0/5713446/92314d043249/ijms-18-02480-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ff0/5713446/efbc6eca12b2/ijms-18-02480-g006.jpg

相似文献

1
Altered Aconitase 2 Activity in Huntington's Disease Peripheral Blood Cells and Mouse Model Striatum.亨廷顿病外周血白细胞和小鼠纹状体中改变的 aconitase 2 活性。
Int J Mol Sci. 2017 Nov 21;18(11):2480. doi: 10.3390/ijms18112480.
2
Targeting ENT1 and adenosine tone for the treatment of Huntington's disease.靶向ENT1和腺苷水平用于治疗亨廷顿舞蹈症。
Hum Mol Genet. 2017 Feb 1;26(3):467-478. doi: 10.1093/hmg/ddw402.
3
A critical window of CAG repeat-length correlates with phenotype severity in the R6/2 mouse model of Huntington's disease.CAG 重复长度的关键窗口与亨廷顿病 R6/2 小鼠模型的表型严重程度相关。
J Neurophysiol. 2012 Jan;107(2):677-91. doi: 10.1152/jn.00762.2011. Epub 2011 Nov 9.
4
AMPK-α1 functions downstream of oxidative stress to mediate neuronal atrophy in Huntington's disease.AMPK-α1在氧化应激下游发挥作用,介导亨廷顿舞蹈病中的神经元萎缩。
Biochim Biophys Acta. 2014 Sep;1842(9):1668-80. doi: 10.1016/j.bbadis.2014.06.012. Epub 2014 Jun 16.
5
N-Acetylcysteine improves mitochondrial function and ameliorates behavioral deficits in the R6/1 mouse model of Huntington's disease.N-乙酰半胱氨酸可改善亨廷顿舞蹈病R6/1小鼠模型的线粒体功能并减轻行为缺陷。
Transl Psychiatry. 2015 Jan 6;5(1):e492. doi: 10.1038/tp.2014.131.
6
Downregulation of genes involved in metabolism and oxidative stress in the peripheral leukocytes of Huntington's disease patients.亨廷顿病患者外周血白细胞中代谢和氧化应激相关基因的下调。
PLoS One. 2012;7(9):e46492. doi: 10.1371/journal.pone.0046492. Epub 2012 Sep 27.
7
Plasma inflammatory biomarkers for Huntington's disease patients and mouse model.亨廷顿病患者和小鼠模型的血浆炎症生物标志物。
Brain Behav Immun. 2015 Feb;44:121-7. doi: 10.1016/j.bbi.2014.09.011. Epub 2014 Sep 28.
8
Formation of polyglutamine inclusions in a wide range of non-CNS tissues in the HdhQ150 knock-in mouse model of Huntington's disease.亨廷顿病 HdhQ150 敲入小鼠模型中非 CNS 组织中聚谷氨酰胺包涵体的形成。
PLoS One. 2009 Nov 30;4(11):e8025. doi: 10.1371/journal.pone.0008025.
9
Neuronal aggregates are associated with phenotypic onset in the R6/2 Huntington's disease transgenic mouse.神经元聚集与 R6/2 亨廷顿病转基因小鼠的表型起始有关。
Behav Brain Res. 2012 Apr 15;229(2):308-19. doi: 10.1016/j.bbr.2011.12.045. Epub 2012 Jan 28.
10
Loss of striatal 90-kDa ribosomal S6 kinase (Rsk) is a key factor for motor, synaptic and transcription dysfunction in Huntington's disease.纹状体90 kDa核糖体S6激酶(Rsk)的缺失是亨廷顿舞蹈病中运动、突触和转录功能障碍的关键因素。
Biochim Biophys Acta. 2016 Jul;1862(7):1255-66. doi: 10.1016/j.bbadis.2016.04.002. Epub 2016 Apr 6.

引用本文的文献

1
Oxidative Stress in Huntington's Disease.亨廷顿舞蹈症中的氧化应激
Biomolecules. 2025 Apr 4;15(4):527. doi: 10.3390/biom15040527.
2
Mitochondrial Aconitase and Its Contribution to the Pathogenesis of Neurodegenerative Diseases.线粒体柠檬酸合酶及其在神经退行性疾病发病机制中的作用。
Int J Mol Sci. 2024 Sep 15;25(18):9950. doi: 10.3390/ijms25189950.
3
Interactions of amyloidogenic proteins with mitochondrial protein import machinery in aging-related neurodegenerative diseases.衰老相关神经退行性疾病中淀粉样蛋白与线粒体蛋白导入机制的相互作用。

本文引用的文献

1
Novel Metabolic Abnormalities in the Tricarboxylic Acid Cycle in Peripheral Cells From Huntington's Disease Patients.亨廷顿病患者外周细胞三羧酸循环中的新型代谢异常
PLoS One. 2016 Sep 9;11(9):e0160384. doi: 10.1371/journal.pone.0160384. eCollection 2016.
2
Metabolic disturbances in plasma as biomarkers for Huntington's disease.血浆代谢紊乱作为亨廷顿病的生物标志物。
J Nutr Biochem. 2016 May;31:38-44. doi: 10.1016/j.jnutbio.2015.12.001. Epub 2016 Jan 4.
3
N-Acetylcysteine improves mitochondrial function and ameliorates behavioral deficits in the R6/1 mouse model of Huntington's disease.
Front Physiol. 2023 Nov 2;14:1263420. doi: 10.3389/fphys.2023.1263420. eCollection 2023.
4
ACO2 deficiency increases vulnerability to Parkinson's disease via dysregulating mitochondrial function and histone acetylation-mediated transcription of autophagy genes.ACO2 缺乏通过调节线粒体功能和组蛋白乙酰化介导的自噬基因转录增加帕金森病易感性。
Commun Biol. 2023 Nov 25;6(1):1201. doi: 10.1038/s42003-023-05570-y.
5
Mitochondrial Aconitase Enzymatic Activity: A Potential Long-Term Survival Biomarker in the Blood of ALS Patients.线粒体乌头酸酶活性:肌萎缩侧索硬化症患者血液中一种潜在的长期生存生物标志物
J Clin Med. 2023 May 19;12(10):3560. doi: 10.3390/jcm12103560.
6
Mitochondria in Huntington's disease: implications in pathogenesis and mitochondrial-targeted therapeutic strategies.亨廷顿舞蹈病中的线粒体:对发病机制的影响及线粒体靶向治疗策略
Neural Regen Res. 2023 Jul;18(7):1472-1477. doi: 10.4103/1673-5374.360289.
7
Reactive Species in Huntington Disease: Are They Really the Radicals You Want to Catch?亨廷顿舞蹈病中的反应性物种:它们真的是你想要捕捉的自由基吗?
Antioxidants (Basel). 2020 Jul 2;9(7):577. doi: 10.3390/antiox9070577.
8
Mitochondrial Dysfunctions: A Red Thread across Neurodegenerative Diseases.线粒体功能障碍:神经退行性疾病的共同线索
Int J Mol Sci. 2020 May 25;21(10):3719. doi: 10.3390/ijms21103719.
9
Changes in mitochondrial function in patients with neuromyelitis optica; correlations with motor and cognitive disabilities.视神经脊髓炎患者中线粒体功能的变化;与运动和认知障碍的相关性。
PLoS One. 2020 Mar 26;15(3):e0230691. doi: 10.1371/journal.pone.0230691. eCollection 2020.
10
Knockout of causes early embryonic death in rats.敲除(某基因)会导致大鼠早期胚胎死亡。 (你原文中“Knockout of ”后面缺少具体基因信息)
Animal Model Exp Med. 2019 Mar 12;2(1):18-24. doi: 10.1002/ame2.12059. eCollection 2019 Mar.
N-乙酰半胱氨酸可改善亨廷顿舞蹈病R6/1小鼠模型的线粒体功能并减轻行为缺陷。
Transl Psychiatry. 2015 Jan 6;5(1):e492. doi: 10.1038/tp.2014.131.
4
Plasma inflammatory biomarkers for Huntington's disease patients and mouse model.亨廷顿病患者和小鼠模型的血浆炎症生物标志物。
Brain Behav Immun. 2015 Feb;44:121-7. doi: 10.1016/j.bbi.2014.09.011. Epub 2014 Sep 28.
5
Downregulation of genes involved in metabolism and oxidative stress in the peripheral leukocytes of Huntington's disease patients.亨廷顿病患者外周血白细胞中代谢和氧化应激相关基因的下调。
PLoS One. 2012;7(9):e46492. doi: 10.1371/journal.pone.0046492. Epub 2012 Sep 27.
6
Transcriptional modulator H2A histone family, member Y (H2AFY) marks Huntington disease activity in man and mouse.转录调节剂 H2A 组蛋白家族成员 Y(H2AFY)在人和小鼠中标记亨廷顿病的活性。
Proc Natl Acad Sci U S A. 2011 Oct 11;108(41):17141-6. doi: 10.1073/pnas.1104409108. Epub 2011 Oct 3.
7
Reduced creatine kinase as a central and peripheral biomarker in Huntington's disease.肌酸激酶降低作为亨廷顿舞蹈病的中枢和外周生物标志物
Biochim Biophys Acta. 2010 Jul-Aug;1802(7-8):673-81. doi: 10.1016/j.bbadis.2010.05.001. Epub 2010 May 9.
8
Triterpenoids CDDO-ethyl amide and CDDO-trifluoroethyl amide improve the behavioral phenotype and brain pathology in a transgenic mouse model of Huntington's disease.三萜烯 CDDO-乙基酰胺和 CDDO-三氟乙基酰胺可改善亨廷顿病转基因小鼠模型的行为表型和脑部病变。
Free Radic Biol Med. 2010 Jul 15;49(2):147-58. doi: 10.1016/j.freeradbiomed.2010.03.017. Epub 2010 Mar 23.
9
Targeting glial cells to elucidate the pathogenesis of Huntington's disease.针对神经胶质细胞阐明亨廷顿病的发病机制。
Mol Neurobiol. 2010 Jun;41(2-3):248-55. doi: 10.1007/s12035-009-8097-5. Epub 2010 Jan 28.
10
Combination therapy with coenzyme Q10 and creatine produces additive neuroprotective effects in models of Parkinson's and Huntington's diseases.在帕金森病和亨廷顿舞蹈病模型中,辅酶Q10和肌酸联合治疗产生相加性神经保护作用。
J Neurochem. 2009 Jun;109(5):1427-39. doi: 10.1111/j.1471-4159.2009.06074.x. Epub 2009 Mar 28.